Trial intelligence / Profile preview

EEE Vaccine Safety and Immunogenicity Study

NCT02654509Phase 2Completed

Sponsor
U.S. Army Medical Research and Development Command
Start
Jun 2008
Primary completion
Feb 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of inactivated eastern equine encephalitis vaccine TSI-GSD 104 in eastern equine encephalitis (EEE), sponsored by U.S. Army Medical Research and Development Command. Started Jun 2008; status: completed.

02

Drugs

inactivated eastern equine encephalitis vaccine TSI-GSD 104
03

Conditions

eastern equine encephalitis (EEE)

Beyond the preview

Go deeper on NCT02654509.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02654509.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call